1、Reinventing biopharma from lab to line Fueling smarter,faster and scalable biopharma production with intelligent technologiesAuthorsSelen Karaca-GriffinSelen is Accentures Research Lead for Products and Life Sciences globally,where she oversees a team of 30+researchers.She shapes the industrys thoug

2、ht leadership agenda,driving insights on scientific innovation,the convergence of science and technology,and market disruptions redefining the future of industries.Selen brings deep experience across both strategy consulting and research leadership.In her current role,she develops CEO perspectives a

3、nd curates Accentures annual Life Sciences CEO Forum,engaging industry leaders on the most pressing issues of the future.Prior to consulting,Selen worked as a scientist and process development engineer at leading biopharmaceutical companies,where she focused on cell line development and bioprocess d

4、esign.Based in Boston,Massachusetts,she also serves on the Biotechnology Industrial Advisory Board at Northeastern University.Hagen SpthHagen is a Managing Director responsible for Accentures Industry X Life Sciences offering in EMEA.He has approximately 25 years of experience in manufacturing,with

5、a specific focus on large biopharma manufacturing for the past 12 years.Hagen has led numerous high-profile projects for large biopharma companies,including IT/OT partnerships,clinical study control towers and digital therapeutics development.He helps clients achieve flexibility and operational exce

6、llence through digital transformation in the life sciences sector.Anne Marie OHalloranLife Sciences Supply Chain&Operations,Americas LeadLife Sciences Industry X EMEA LeadProducts and Life Sciences Thought Leadership,Accenture ResearchContributorsBarry HeaveyBrendan Hughes,Ph.DBPHughes CMC Consultin